Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Soleno Therapeutics (SLNO) Preferred Shares Issued (2016)

Soleno Therapeutics (SLNO) has disclosed Preferred Shares Issued for 1 consecutive years, with -$8.4 million as the latest value for Q4 2016.

  • On a quarterly basis, Preferred Shares Issued changed N/A to -$8.4 million in Q4 2016 year-over-year; TTM through Sep 2017 was -$8.4 million, a 162.38% decrease, with the full-year FY2016 number at $5.1 million, changed N/A from a year prior.
  • Preferred Shares Issued was -$8.4 million for Q4 2016 at Soleno Therapeutics, down from $8.4 million in the prior quarter.
  • In the past five years, Preferred Shares Issued ranged from a high of $8.4 million in Q3 2016 to a low of -$8.4 million in Q4 2016.